NXTC

Nextcure

• Dow Jones·05/11 19:27

  NextCure Price Target Announced at $25.00/Share by LUCID CAPITAL MARKETS

• Dow Jones·05/11 19:27

  NextCure Initiated at Buy by LUCID CAPITAL MARKETS

• Benzinga·05/11 19:17

  LUCID CAPITAL MARKETS Initiates Coverage On NextCure with Buy Rating, Announces Price Target of $25

• TipRanks·05/11 12:05

  NextCure initiated with a Buy at Lucid Capital

• Seeking Alpha·05/07 21:43

  NextCure GAAP EPS of -$1.87 beats by $0.16

• PUBT·05/07 21:11

  NextCure publishes corporate presentation on Phase 1 antibody-drug conjugate cancer programs

• Benzinga·05/07 20:33

  NextCure Q1 EPS $(1.87) Beats $(2.12) Estimate

• Dow Jones·05/07 20:05

  Press Release: NextCure Provides Business Update -2-

• TipRanks·05/04 12:10

  NextCure initiates dose optimization portion of SIM0505 study

• PUBT·05/04 11:06

  NextCure starts Phase 1 dose optimization study of SIM0505 in platinum-resistant ovarian cancer

• Reuters·05/04 11:05

  NEXTCURE - ACCELERATING DEVELOPMENT OF PROGRAM BY INCREASING NUMBER OF U.S. AND CHINA TRIAL SITES

• Reuters·05/04 11:05

  NEXTCURE AND SIMCERE ZAIMING INITIATE DOSE OPTIMIZATION FOR SIM0505 (CDH6 ADC) IN GYNECOLOGIC CANCERS

• Reuters·05/04 11:05

  NEXTCURE - ACCELERATING DEVELOPMENT OF PROGRAM BY EXPANDING OUR CLINICAL SITE FOOTPRINT INTO CANADA AND EUROPE

• PUBT·04/24 20:21

  NextCure announces annual shareholder meeting to be held virtually

• Benzinga·04/24 17:05

  12 Health Care Stocks Moving In Friday's Intraday Session